Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapy for treating cancer with an intravenous administration of a recombinant MVA and an antibody

Combination therapy for treating cancer with an intravenous administration of a recombinant MVA and an antibody

US Patent 11273211 · Granted Mar 15, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapy for treating cancer with an intratumoral or intravenous administration o2025
Therapy for treating cancer with an intratumoral or intravenous administration o2025
Combination therapy for treating cancer with an antibody and intravenous adminis2023
Combination therapy for treating cancer with an antibody and intravenous adminis2023
Combination therapy for treating cancer with an antibody and intravenous adminis2023
Combination therapy for treating cancer with an antibody and intravenous adminis2023
Multivalent recombinant modified vaccinia virus ankara (MVA) vector encoding fil2022
Multivalent recombinant modified vaccinia virus ankara (MVA) vector encoding fil2022
Methods and compositions for enhancing vaccine immune responses2021
Methods and compositions for enhancing vaccine immune responses2021
Recombinant modified vaccinia virus Ankara (MVA) multivalent filovirus immunogen2020
Recombinant modified vaccinia virus Ankara (MVA) multivalent filovirus immunogen2020